The global colposcope market size is expected to reach USD 537.08 million by 2030, registering a CAGR of 4.6% during the forecast period, according to a new report by Grand View Research, Inc. Increase in the prevalence of cervical cancer, technological advancements, and the rising demand for early- diagnosis of gynecological disorders are expected to boost the market growth. According to the ICO Information Centre on HPV and Cancer, cervical cancer is the fourth most frequent cancer among women globally, with an estimated 604,127 new cases and 341,831 deaths in 2020.
An article published by the Human Papillomavirus Information Center stated that cervical cancer is reported to be the second most common cancer among women aged 15 to 44. Colposcopy helps in accurate identification of cervical pre-cancer and early invasive cancer. Moreover, colposcope directed biopsies of severe lesion visualized help in further management of the disease. Growing awareness and rise in the number of screening campaigns for cervical cancer conducted by governments of various regions are expected to fuel the market growth during the forecast period.
In the U.S., National Breast and Cervical Cancer Early Detection Program (NBCCEDP) offers breast and cervical cancer screening and diagnostic services to low-income, uninsured, and underinsured women across the country. Several obstacles arose as a result of the COVID-19 pandemic, including logistical constraints, low demand, and reduced sales and marketing activities. However, by mid-2022, the market is predicted to be steadily improving. By encouraging end-users to embrace high-end technologies for early diagnosis of the disease, aiming to lessen cervical cancer cases by 70%, and thus preventing over 4.5 million deaths (Source: WHO). This is expected to significantly boost the market in the coming years.
Request a free sample copy or view report summary: Colposcope Market Report
The video colposcope segment is expected to grow at the fastest rate during the forecast period
Based on application, the oral examination segment is expected to grow the fastest rate during the forecast period.
Based on portability, the handheld segment is estimated to register the fastest growth rate during the forecast period, owing to its ease of use and compact nature
The hospital segment held the largest revenue share based on end-use in 2023
North America dominated the market and accounted for the largest revenue share in 2023
In Asia Pacific, the market is anticipated to witness the fastest CAGR over the forecast period owing to the growing need for technologically advanced and cost-effective healthcare solutions
Grand View Research has segmented the global colposcope market based on modality, application, portability, end-use, and region:
Colposcope Modality Outlook (Revenue, USD Million, 2018 - 2030)
Optical
Video
Colposcope Application Outlook (Revenue, USD Million, 2018 - 2030)
Pelvic
Oral
Colposcope Portability Outlook (Revenue, USD Million, 2018 - 2030)
Handheld
Stationary
Colposcope End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Diagnostic Centers
Gynaecology Clinic
Speciality Clinics
Ambulatory Surgical Center
Research and Academics
Colposcope Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Sweden
Norway
Denmark
Asia Pacific
China
Japan
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East and Africa
Saudi Arabia
South Africa
UAE
Kuwait
List of Key Players of Colposcope Market
Kaps GmbH & Co. KG
Carl Zeiss Meditec AG
CooperSurgical, Inc
DYSIS Medical Inc
ATMOS Medizin Technik GmbH & Co. KG
Olympus Corporation
McKesson Medical-Surgical Inc.
Ecleris
Optomic
Seiler Instrument Inc.
"The quality of research they have done for us has been excellent..."